₹41.20
-0.70 (-1.67%)
As of 28 Aug 2026, Zenith Drugs Ltd share price is ₹41.20. The stock opened at ₹41.20 and had closed at ₹41.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹33.30 and a high of ₹73.45. In terms of performance, Zenith Drugs Ltd share price has decreased by 15.92% over the past six months and has decreased by 39.90% over the last year.
ZENITHDRUG Charts
Zenith Drugs Ltd Overview
Market cap₹71 Crs
Volume4,000
Prev. Close₹41.90
Year range₹33.30 - ₹73.45
Total Value₹1,64,800.00
ISININE0QWN01013
About ZENITHDRUG
Zenith Drugs is a leading manufacturer of a range of healthcare drugs and allied products.
Zenith Drugs Ltd Historical Performance
1 Month Return-15.92%
6 Month Return-16.77%
3 Year Return-
3 Month Return-9.35%
1 Year Return-40.25%
5 Year Return-
Zenith Drugs Ltd Fundamental Analysis
ROCE(TTM)8.46%
P/E Ratio (TTM)17.91
P/B Ratio0.94
Debt to Equity0.74
ROE5.26%
EPS (TTM)2.42
Dividend Yield0.00%
Book Value43.69
Profit Margin0.00%
Operating Margin0.00%
Zenith Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 42.10 |
| MACD | -1.46 |
| 20-Day SMA | 44.26 |
Zenith Drugs Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Zenith Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Zenith Drugs Ltd today is ₹41.20 on NSE and ₹41.20 on BSE.
- The 52-week high of Zenith Drugs Ltd is ₹73.45, while the 52-week low is ₹33.30.
- The current market capitalisation of Zenith Drugs Ltd is approximately ₹71 crore.
- The P/E (Price-to-Earnings) ratio of Zenith Drugs Ltd is 8.17. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Zenith Drugs Ltd is 1.27. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Zenith Drugs Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Zenith Drugs Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Zenith Drugs Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Zenith Drugs Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 69.98% promoters, 0.00% FIIs, 0.00% DIIs, and 24.73% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
